Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells Astrid BernhausMaria Ozsvar-KozmaThomas Szekeres PRECLINICAL STUDIES 08 October 2008 Pages: 393 - 401
Characterization of the cytotoxic activity of the indoloquinoline alkaloid cryptolepine in human tumour cell lines and primary cultures of tumour cells from patients Daniel LaryeaAnders IsakssonPeter Nygren PRECLINICAL STUDIES 14 October 2008 Pages: 402 - 411
Artemisinin reduces human melanoma cell migration by down-regulating αVβ3 integrin and reducing metalloproteinase 2 production Elisabetta BuomminoAdone BaroniMaria Antonietta Tufano PRECLINICAL STUDIES 28 October 2008 Pages: 412 - 418
Amino acetate functionalized Schiff base organotin(IV) complexes as anticancer drugs: synthesis, structural characterization, and in vitro cytotoxicity studies Tushar S. Basu BaulSmita BasuAnthony Linden PRECLINICAL STUDIES 22 October 2008 Pages: 419 - 431
Mixed steroidal tetraoxanes induce apoptotic cell death in tumor cells Željko ŽižakZorica JuranićBogdan A. Šolaja PRECLINICAL STUDIES 15 November 2008 Pages: 432 - 439
Extracts of marine sponge Polymastia janeirensis induce oxidative cell death through a caspase-9 apoptotic pathway in human U138MG glioma cell line Mario Luiz Conte da Frota Jr.Elizandra BraganholJosé Cláudio Fonseca Moreira PRECLINICAL STUDIES 11 November 2008 Pages: 440 - 446
Protective role of Withaferin-A on immunoexpression of p53 and bcl-2 in 7,12-dimethylbenz(a)anthracene-induced experimental oral carcinogenesis Kuppusamy PanjamurthyShanmugam ManoharanLakshmanan Vellaichamy PRECLINICAL STUDIES 14 November 2008 Pages: 447 - 452
Phase I trial of docetaxel given every 3 weeks and daily lenalidomide in patients with advanced solid tumors Sharon L. SanbornJoseph GibbonsMatthew M. Cooney PHASE I STUDIES 15 November 2008 Pages: 453 - 460
A phase I study of an oral simulated FOLFOX with high dose capecitabine D. MulkerinN. K. LoConteG. Wilding PHASE I STUDIES 08 January 2009 Pages: 461 - 468
Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336) Robert P. WhiteheadCathryn RankinCharles D. Blanke PHASE II STUDIES 22 October 2008 Pages: 469 - 475
Results of a Phase II trial of gemcitabine, mitoxantrone, and rituximab in relapsed or refractory mantle cell lymphoma Lawrence E. GarboPatrick J. FlynnKathryn S. Kolibaba PHASE II STUDIES 25 October 2008 Pages: 476 - 481
Phase III trial of standard versus dose-intensified doxorubicin, ifosfamide and dacarbazine (MAID) in the first-line treatment of metastatic and locally advanced soft tissue sarcoma Jérôme FayetteNicolas PenelBinh Bui-Nguyen PHASE III STUDIES 16 January 2009 Pages: 482 - 489